Skip to content

Drug interactions

Lemborexant + Vincristine

Severity: Minor

Lemborexant and Vincristine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vincristine is reported to weakly inhibit CYP3A4, which could modestly raise lemborexant levels. This may increase next-day somnolence and impaired alertness.

What this interaction means in plain words

Lemborexant and Vincristine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lemborexant belongs to Central Nervous System; Vincristine belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by vincristine reducing lemborexant metabolism.

What to do

Monitor for daytime sedation and impaired psychomotor function. Consider the lower lemborexant dose if excess sedation occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lemborexant and Vincristine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lemborexant with Vincristine?

MediHelp rates the interaction as minor. Lemborexant and Vincristine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vincristine is reported to weakly inhibit CYP3A4, which could modestly raise lemborexant levels. This may increase next-day somnolence and impaired alertness.

How serious is the interaction between Lemborexant and Vincristine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for daytime sedation and impaired psychomotor function. Consider the lower lemborexant dose if excess sedation occurs.

What other medicines interact with Vincristine?

MediHelp also lists interactions of Vincristine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Atazanavir. The full list is on the Vincristine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in